Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism

Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism

Zi-Zheng Song, 1 Li-Fen Zhao, 2 Jing Zuo, 3 Zhi-Song Fan, 3 Long Wang, 3 Yu-Dong Wang 3 1Department of Medical Oncology, The Affiliated Hospital of Hebei University, Baoding, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, The Shanxi Dayi Hospital, Taiy...

Full description

Bibliographic Details
Main Authors:	Song ZZ, Zhao LF, Zuo J, Fan ZS, Wang L, Wang YD
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-01-01
Series:	OncoTargets and Therapy
Subjects:	non-small cell lung cancer apatinib kinase insert domain receptor polymorphism clinical outcomes safety
Online Access:	https://www.dovepress.com/clinical-outcomes-and-safety-of-apatinib-mesylate-in-the-treatment-of--peer-reviewed-article-OTT

Similar Items

Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment
by: Bai M, et al.
Published: (2021-03-01)

Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report
by: Lishu Yang, et al.
Published: (2018-05-01)

Apatinib mesylate tablet in the treatment of advanced malignant melanoma
by: Yang L, et al.
Published: (2018-08-01)

Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multiline chemotherapy and apatinib: A case report and literature review
by: Ran Zuo, et al.
Published: (2020-11-01)

Apatinib-treated advanced medullary thyroid carcinoma: a case report
by: Chen K, et al.
Published: (2018-01-01)

Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
by: Li J, et al.
Published: (2017-08-01)

Progress of Apatinib in Treatment of Non-small Cell Lung Cancer
by: LIANG Lijun, et al.
Published: (2018-11-01)

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
by: Zhonghan Zhang, et al.
Published: (2019-11-01)

Apatinib Mesylate Inhibits the Proliferation and Metastasis of Epithelioid Malignant Peritoneal Mesothelioma In Vitro and In Vivo
by: Zhi-Ran Yang, et al.
Published: (2020-12-01)

Efficacy and Safety of Apatinib in the Treatment of Postoperative Recurrence of Fibrosarcoma
by: Ma H, et al.
Published: (2020-02-01)

Safety and efficacy of combination therapy with apatinib and doxorubicin in metastatic soft tissue sarcomas: an observational study from multiple institutions
by: Tian Z, et al.
Published: (2019-06-01)

Efficacy and Response Biomarkers of Apatinib in the Treatment of Malignancies in China: A Review
by: Zhichao Tian, et al.
Published: (2021-10-01)

Research Progress on Antitumor Mechanism of Apatinib
by: ZHAO Lingying, et al.
Published: (2021-01-01)

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
by: Li X, et al.
Published: (2018-07-01)

Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways
by: Zhen H, et al.
Published: (2020-12-01)

The effect of apatinib combined with chemotherapy or targeted therapy on non‐small cell lung cancer in vitro and vivo
by: Mingtao Liu, et al.
Published: (2019-10-01)

Apatinib for advanced sarcoma: results from multiple institutions’ off-label use in China
by: Lu Xie, et al.
Published: (2018-04-01)

Case Report: Favorable Response to the Tyrosine Kinase Inhibitor Apatinib in Recurrent Merkel Cell Carcinoma
by: Yiyi Feng, et al.
Published: (2021-03-01)

A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
by: Yang M, et al.
Published: (2019-10-01)

Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer‐bearing mice and patients
by: Mingtao Liu, et al.
Published: (2020-04-01)

Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma
by: Xie L, et al.
Published: (2020-01-01)

Effect of Apatinib on Invasion and Migration of Lung Cancer Cells and Its Mechanism
by: Yin YUAN, et al.
Published: (2019-05-01)

Research Progress of Combination Therapy of Apatinib on Tumor
by: WU Shan, et al.
Published: (2019-03-01)

Progress in the treatment of solid tumors with apatinib: a systematic review
by: Zhao D, et al.
Published: (2018-07-01)

Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy
by: Radwan SES, et al.
Published: (2021-07-01)

Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report
by: Jieshan Guan, et al.
Published: (2019-12-01)

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study
by: Lin H, et al.
Published: (2019-02-01)

Salvage treatment with apatinib for advanced non-small-cell lung cancer
by: Song Z, et al.
Published: (2017-03-01)

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation
by: Zeng D, et al.
Published: (2017-08-01)

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study
by: Geng Q, et al.
Published: (2020-11-01)

Therapeutic Effect of Apatinib in First-line Treatment of Advanced Liver Cancer
by: KE Shaobo, et al.
Published: (2021-07-01)

Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment
by: Xuemin WANG, et al.
Published: (2017-11-01)

Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial
by: Shuo Wu, et al.
Published: (2020-05-01)

Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
by: Guohui Liu, et al.
Published: (2019-10-01)

Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib
by: Fang SC, et al.
Published: (2019-02-01)

Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients
by: Hui Yao, et al.
Published: (2021-04-01)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
by: Xu Z, et al.
Published: (2019-05-01)

Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma—A Retrospective Analysis of a Multicenter Clinical Study
by: Xue Yang, et al.
Published: (2021-05-01)

Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis
by: Wu J, et al.
Published: (2018-05-01)

Efficacy and safety of apatinib treatment for gastric cancer, hepatocellular carcinoma and non-small cell lung cancer: a meta-analysis
by: Xue J, et al.
Published: (2018-09-01)